BioNTech (NASDAQ:BNTX) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded shares of BioNTech (NASDAQ:BNTX – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning. Other equities analysts have also issued research reports about the stock. Morgan Stanley reduced their price target on shares of BioNTech from $140.00 to $132.00 and set an […]
